Two Sigma Investments
EPRX

Two Sigma Investments’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Two Sigma Investments’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.2K Buy
+10,800
New +$86.9K ﹤0.01% 4416

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Two Sigma Investments's EPRX Position: Q1 2026 in Review

Two Sigma Investments opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q1 2026: 10,800 shares worth $78.2K. The stake represents ﹤0.01% of the portfolio and ranks #4416 among its holdings.

54 funds tracked by Wall St. Rank hold EPRX as of Q1 2026.

  • Two Sigma Investments held 10,800 shares of Eupraxia Pharmaceuticals worth $78.2K as of Q1 2026.
  • Eupraxia Pharmaceuticals was a new Two Sigma Investments position in Q1 2026.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4416 holding.
  • 54 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.